Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666991 | SCV000791375 | uncertain significance | Autosomal recessive polycystic kidney disease | 2017-05-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002499157 | SCV002812240 | uncertain significance | Polycystic kidney disease 4 | 2022-05-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000666991 | SCV003265567 | pathogenic | Autosomal recessive polycystic kidney disease | 2023-08-04 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PKHD1 protein function. ClinVar contains an entry for this variant (Variation ID: 551838). This missense change has been observed in individual(s) with autosomal recessive polycystic kidney disease and/or PKHD1-related conditions (PMID: 27225849; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs754448530, gnomAD 0.003%). This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 270 of the PKHD1 protein (p.Ser270Arg). For these reasons, this variant has been classified as Pathogenic. |